Adeno-associated virus vectors: activity and applications in the CNS

被引:127
作者
Peel, AL
Klein, RL
机构
[1] Buck Ctr Res Aging, Novato, CA 94948 USA
[2] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA
关键词
adeno-associated virus (AAV); disease-modeling; gene therapy; gene transfer; neurodegenerative disease; neurotrophic factor;
D O I
10.1016/S0165-0270(00)00183-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Transgenic strategies are useful for functional studies and they may also lead to novel therapies. Controlling transgene expression in defined cell populations over time is increasingly important for both functional and gene therapy experiments. The adeno-associated virus (AAV) vector may provide sufficient spatio-temporal control of gene expression for these purposes. This paper reviews in vivo somatic gene transfer methodology using AAV. Advantageous features of this system include neuronal gene expression that is: (1) efficient; (2) long-lived; and (3) non-toxic. Thus, AAV-mediated gene transfer is a good method for functional genomic research. From characterizing vector activity in the brain using different combinations of promoters and transgenes in the mid to late 1990s, researchers continue to discover novel uses of AAV for both basic and clinical neuroscience. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:95 / 104
页数:10
相关论文
共 67 条
[1]   Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production [J].
Allen, JM ;
Debelak, DJ ;
Reynolds, TC ;
Miller, AD .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6816-6822
[2]   HERPESVIRUS-MEDIATED GENE DELIVERY INTO THE RAT-BRAIN - SPECIFICITY AND EFFICIENCY OF THE NEURON-SPECIFIC ENOLASE PROMOTER [J].
ANDERSEN, JK ;
FRIM, DM ;
ISACSON, O ;
BREAKEFIELD, XO .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1993, 13 (05) :503-515
[3]   ROLE OF HERPESVIRUSES IN ADENOVIRUS-ASSOCIATED VIRUS REPLICATION IN-VITRO [J].
ATCHISON, RW .
VIROLOGY, 1970, 42 (01) :155-&
[4]   Selective and rapid uptake of adeno-associated virus type 2 in brain [J].
Bartlett, JS ;
Samulski, RJ ;
McCown, TJ .
HUMAN GENE THERAPY, 1998, 9 (08) :1181-1186
[5]   Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease [J].
BilangBleuel, A ;
Revah, F ;
Colin, P ;
Locquet, I ;
Robert, JJ ;
Mallet, J ;
Horellou, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (16) :8818-8823
[6]  
Blomer U, 1997, J VIROL, V71, P6641
[7]   GFAP PROMOTER DIRECTS ASTROCYTE-SPECIFIC EXPRESSION IN TRANSGENIC MICE [J].
BRENNER, M ;
KISSEBERTH, WC ;
SU, Y ;
BESNARD, F ;
MESSING, A .
JOURNAL OF NEUROSCIENCE, 1994, 14 (03) :1030-1037
[8]   CHRONIC L-DOPA TREATMENT IN THE UNILATERAL 6-OHDA RAT - EVIDENCE FOR BEHAVIORAL SENSITIZATION AND BIOCHEMICAL TOLERANCE [J].
CAREY, RJ .
BRAIN RESEARCH, 1991, 568 (1-2) :205-214
[9]   STUDIES ON RELATIONSHIP BETWEEN ADENO-ASSOCIATED VIRUS TYPE I (AAV-1) AND ADENOVIRUSES .I. REPLICATION OF AAV-1 IN CERTAIN CELL CULTURES AND ITS EFFECT ON HELPER ADENOVIRUS [J].
CASTO, BC ;
ATCHISON, RW ;
HAMMON, WM .
VIROLOGY, 1967, 32 (01) :52-+
[10]   Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS [J].
Chamberlin, NL ;
Du, B ;
de Lacalle, S ;
Saper, CB .
BRAIN RESEARCH, 1998, 793 (1-2) :169-175